Coronaviruses and SARS-CoV-2: A Brief Overview.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32243297.
- Also identified by DOI 10.1213/ANE.0000000000004845 and PMC identifier 7173023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In late December 2019, several cases of pneumonia of unknown origin were reported from China, which in early January 2020 were announced to be caused by a novel coronavirus. The virus was later denominated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and defined as the causal agent of coronavirus disease 2019 (COVID-19). Despite massive attempts to contain the disease in China, the virus has spread globally, and COVID-19 was declared a pandemic by the World Health Organization (WHO) in March 2020. Here we provide a short background on coronaviruses, and describe in more detail the novel SARS-CoV-2 and attempts to identify effective therapies against COVID-19.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Pneumonia, Viral